Prot #M15-997: A multicenter, open Label study to assess the safety and efficacy of rIsankizuMab for MaInTenance in moderate to severe pLaquE type pSoriaSis (LIMMITLESS)

Project: Research project

StatusActive
Effective start/end date5/24/175/24/21

Funding

  • AbbVie Inc. (Prot #M15-997)